Celebrating 25 Years of Nexstim: From Finnish Research to Global Impact

This October, Nexstim proudly celebrates 25 years since its founding in 2000. The journey began with a bold scientific vision: to make transcranial magnetic stimulation (TMS) visible, accurate, and reproducible.

Born from pioneering research led by Professor Risto Ilmoniemi and his team at Helsinki University of Technology and the BioMag Laboratory, Nexstim was founded on the breakthrough insight that by calculating and visualizing the electric field (E-field) induced in the brain by TMS, it could be utilized with high accuracy and precision.

To ensure this accuracy, Nexstim committed early to fully integrating hardware, software and navigation in one device. This philosophy led to FDA clearances and CE marking for pre-procedural brain mapping and was followed by FDA approval and a CE mark for the treatment of major depressive disorder, and a CE mark for the treatment of unilateral chronic neuropathic pain.

Today, Nexstim's proprietary technology is used worldwide for both neurosurgical planning and personalized therapy, enabling clinicians to deliver targeted and reproducible nTMS. Recent partnerships with Brainlab and Sinaptica Therapeutics are bringing tailwind to Nexstim nTMS. With the release of our new, easy-to-use NBS 6 product generation, we are looking forward to bringing E-field navigated TMS to even more clinicians and patients.

As we celebrate this 25-year milestone, we want to express our gratitude to everyone who joined this endeavour: researchers, clinicians, collaborators, employees, former employees, partners and patients, who put their trust in what Nexstim nTMS can do and continue to innovate, to bring nTMS to even more patients.

Our mission remains unchanged - onto the next 25 years!

If you are curious to see how far we have come, have a look at the image gallery below!